Enteric fever, encompassing typhoid and paratyphoid fever, is a systemic infection primarily caused by Salmonella Typhi and Salmonella Paratyphi. Despite advancements in medical science, its diagnosis and management continue to pose challenges due to varying clinical manifestations and increasing antibiotic resistance.
Early diagnosis is crucial for effective management of enteric fever. Blood culture remains the gold standard for diagnosis, although it has limitations such as time consumption and low sensitivity. Other diagnostic modalities include bone marrow culture, stool culture, and serological tests like Widal test. However, these have their own set of limitations. Recent advancements include molecular techniques like PCR, which provide rapid and accurate results.
The increasing resistance of Salmonella species to first-line antimicrobials like chloramphenicol, ampicillin, and co-trimoxazole has necessitated the use of second-line drugs such as fluoroquinolones and cephalosporins. However, emerging resistance to these drugs has been reported. Therefore, susceptibility testing is essential for appropriate antimicrobial selection.
Vaccination plays a significant role in enteric fever prevention. Two vaccines, Vi polysaccharide vaccine and Ty21a vaccine, are currently available. Both vaccines provide a reasonable degree of protection and are recommended for travelers to endemic areas and high-risk populations.
In conclusion, enteric fever remains a significant global health issue. Early diagnosis and appropriate antimicrobial therapy are vital for successful management. Emerging diagnostic techniques and vigilant antimicrobial stewardship can help overcome the challenges posed by this disease. Vaccination remains an important preventive measure. Continuous research and development in these areas are crucial for the effective control and eventual eradication of enteric fever.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation